Ufp Technologies (UFPT) Total Current Liabilities (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Total Current Liabilities came in at $78.3 million in Q2 2026, up 13.16% on a YoY basis from $69.2 million in Q2 2025, and up 1.68% quarter-over-quarter from $77.0 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Total Current Liabilities (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Total Current Liabilities for 17 consecutive years, with $78.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 13.16% year-over-year to $78.3 million; the trailing twelve-month figure through Jun 2026 stood at $78.3 million (up 13.16% YoY), and the FY2025 full-year result was $74.9 million, down 1.88% from the prior year.
- Total Current Liabilities rose to $78.3 million in Q2 2026 per UFPT's latest filing, from $77.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $82.2 million in Q3 2025 and bottomed at $38.8 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $63.7 million across 5 years, with a median of $57.8 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities soared 205.97% in 2022, then declined 3.58% in 2026.
- Over 5 years, Total Current Liabilities stood at $56.0 million in 2022, then increased by 4.02% to $58.2 million in 2023, then jumped by 31.07% to $76.3 million in 2024, then declined by 1.88% to $74.9 million in 2025, then advanced by 4.6% to $78.3 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $78.3 million, $77.0 million, and $74.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.80 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 6.68 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 6.43 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.51 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 3.17 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 2.36 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 78.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.30 Mn |
| Mar 31, 2026 | 77.01 Mn |
| Dec 31, 2025 | 74.86 Mn |
| Sep 30, 2025 | 82.23 Mn |
| Jun 30, 2025 | 69.20 Mn |
| Mar 31, 2025 | 79.87 Mn |
| Dec 31, 2024 | 76.30 Mn |
| Sep 30, 2024 | 78.35 Mn |
| Jun 30, 2024 | 51.79 Mn |
| Mar 31, 2024 | 52.44 Mn |
| Dec 31, 2023 | 58.21 Mn |
| Sep 30, 2023 | 56.59 Mn |
| Jun 30, 2023 | 52.99 Mn |
| Mar 31, 2023 | 52.19 Mn |
| Dec 31, 2022 | 55.96 Mn |
| Sep 30, 2022 | 57.40 Mn |
| Jun 30, 2022 | 53.38 Mn |
| Mar 31, 2022 | 38.82 Mn |
| Dec 31, 2021 | 38.78 Mn |
| Sep 30, 2021 | 18.76 Mn |